Regenerex Pharma (RGPX) Non-Current Debt (2023 - 2024)
Regenerex Pharma (RGPX) reported Non-Current Debt of $184232.0 for Q1 2024, up 6479.71% on a QoQ basis from $2800.0 in Q4 2023.
Regenerex Pharma (RGPX) has 2 years of Non-Current Debt data on file, last reported at $184232.0 in Q1 2024.
- Quarterly Non-Current Debt changed N/A year-over-year to $184232.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $184232.0 (changed N/A YoY) and the FY2024 annual result came in at $184232.0, changed N/A from the prior year.
- Non-Current Debt rose to $184232.0 in Q1 2024 per RGPX's latest filing, from $2800.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $184232.0 in Q1 2024 and bottomed at $2800.0 in Q3 2023.
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 184,232.00 |
| Mar 31, 2024 | 184,232.00 |
| Dec 31, 2023 | 2,800.00 |
| Dec 31, 2023 | 2,800.00 |
| Sep 30, 2023 | 2,800.00 |
| Sep 30, 2023 | 2,800.00 |